U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Ezetimibe/Simvastatin (marketed as Vytorin) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Ezetimibe/Simvastatin (marketed as Vytorin) Information

For current information on Vytorin, please see Simvastatin Information.

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

Labeling and Regulatory History from Drugs@FDA

Back to Top